The Impact of CMV Reactivation on Mortality After Chimeric Antigen Receptor T-Cell Therapy
Blood Adv
.
2025 Apr 9:bloodadvances.2024015164.
doi: 10.1182/bloodadvances.2024015164.
Online ahead of print.
Authors
Eleftheria Kampouri
1
,
Patrick W Flaherty
2
,
Hu Xie
3
,
Mandeep K Sekhon
2
,
Clementine Chalal
2
,
Terry L Stevens-Ayers
2
,
Damian J Green
2
,
Jordan Gauthier
3
,
Mazyar Shadman
3
,
Ailyn C Pérez-Osorio
4
,
Keith R Jerome
3
,
Wendy M Leisenring
2
,
Michael J Boeckh
2
,
Joshua A Hill
2
Affiliations
1
Lausanne University Hospital and University of Lausanne, Switzerland.
2
Fred Hutchinson Cancer Center, Seattle, Washington, United States.
3
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States.
4
University of Washington, Seattle, Washington, United States.
PMID:
40203190
DOI:
10.1182/bloodadvances.2024015164
No abstract available